Stay updated on Fazirsiran Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.

Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe study page adds new guidance and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status now shows 'No longer looking for participants', while the Interventions header is simplified (Intervention/Treatment) and the revision tag is updated to v3.6.0.SummaryDifference0.3%

- Check8 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, signaling a new version of the page. This represents a minor update to the page's documentation/metadata and does not change the study data.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a software update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s footer/site revision was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a software-release change rather than a change to study details.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a related topic entry for Alpha-1-antitrypsin deficiency and a link to the Genetic and Rare Diseases Information Center as a resource.SummaryDifference0.1%

Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.